PGNY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Progyny Inc (PGNY) is not a strong buy at this moment for a beginner investor with a long-term horizon. While the stock has positive long-term growth potential, current technical indicators and insider selling trends suggest waiting for a more favorable entry point.
The MACD histogram is negative and expanding, indicating bearish momentum. RSI is neutral at 50.694, showing no clear signal. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading near its pivot level of 26.238, with key resistance at 27.069 and support at 25.407.
Analysts have raised price targets recently, with a consensus view of favorable growth trends in fertility prescription utilization and assisted reproductive technology cycles. The company has a strong balance sheet and cash flow generation, and it is expected to return to double-digit revenue growth in the second half of 2026.
Insider selling has increased by 601.40% over the last month, which could indicate a lack of confidence from insiders. Additionally, hedge funds are neutral, and there are no significant trading trends. The MACD and other technical indicators suggest bearish momentum in the short term.
No financial data available for analysis.
Analysts are optimistic about Progyny, with multiple firms raising price targets and maintaining Buy or Overweight ratings. The average price target is around $30-$31, indicating potential upside from the current price of $26.08.
